Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage

AUTOR(ES)

Chen, Lihong

FONTE

National Academy of Sciences

RESUMO

The MDM2 oncogene encodes an inhibitor of the p53 tumor suppressor protein that regulates p53 in a negative feedback loop. MDM2 gene amplification and overexpression occur in several types of tumors and are often associated with poor prognosis. An MDM2 antisense phosphorothioate oligodeoxynucleotide has been identified that effectively inhibits MDM2 expression in tumor cells containing MDM2 gene amplifications. Antisense inhibition of MDM2 is associated with a decrease in MDM2–p53 complex formation, increase in p53-inducible gene expression, increase in p53 transcriptional activity, and apoptosis. Significantly, inhibition of MDM2 expression enhances the activation of p53 by a DNA-damaging cancer chemotherapy agent in a synergistic fashion. Therefore, the MDM2 negative feedback pathway is an important limiting factor in DNA damage-induced p53 activation. MDM2 antisense oligonucleotides may be useful as antitumor agents alone or as enhancers of other conventional DNA-damaging drugs.

Documentos Relacionados

• Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation
• ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
• p53 and MDM2 protein expression in actinic cheilitis
• mdm2 expression is induced by wild type p53 activity.
• Regulation of p53 and MDM2 Activity by MTBP